Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2001 3
2002 4
2003 8
2004 4
2005 2
2006 1
2007 1
2008 1
2009 3
2010 1
2011 1
2012 2
2013 3
2014 2
2015 2
2016 3
2017 5
2018 5
2019 1
2020 2
2021 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Marso SP, et al. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Free article. Clinical Trial.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
GLP-1-mediated gene therapy approaches for diabetes treatment.
Tasyurek MH, Altunbas HA, Canatan H, Griffith TS, Sanlioglu S. Tasyurek MH, et al. Among authors: altunbas ha. Expert Rev Mol Med. 2014 Mar 26;16:e7. doi: 10.1017/erm.2014.7. Expert Rev Mol Med. 2014. PMID: 24666581 Review.
Insulin gene therapy from design to beta cell generation.
Sanlioglu AD, Altunbas HA, Balci MK, Griffith TS, Sanlioglu S. Sanlioglu AD, et al. Among authors: altunbas ha. Expert Rev Mol Med. 2012 Oct 15;14:e18. doi: 10.1017/erm.2012.12. Expert Rev Mol Med. 2012. PMID: 23062285 Review.
Clinical Characteristics and Follow-Up Results of Adrenal Incidentaloma.
Yilmaz N, Avsar E, Tazegul G, Sari R, Altunbas H, Balci MK. Yilmaz N, et al. Among authors: altunbas h. Exp Clin Endocrinol Diabetes. 2021 May;129(5):349-356. doi: 10.1055/a-1079-4915. Epub 2020 Jan 20. Exp Clin Endocrinol Diabetes. 2021. PMID: 31958848
57 results